Featured Products 2016

Highlighted products added to the Tocris Bioscience range during 2016

September 2016

High affinity and selective P2Y14 antagonist
4862 | PPTN

KB = 434 nM. Exhibits >10,000-fold selectivity for P2Y14 over other P2Y receptors. Inhibits UDP-glucose and MRS 2690-induced porcine pancreatic artery contraction ex vivo. Also blocks UDP-glucose-induced chemotaxis of HL-60 leukemia cells in vitro.

Related Products: MRS 2690 MRS 2500 AR-C 118925XX
Selective mIDH1 inhibitor; phenotypically lethal
5244 | TC-E 5008

Ki = 120-190 nM. Displays >60-fold selectivity for mIDH1 (found in ~75% of gliomas) over wild type IDH1. Also inhibits D-2-hydroxyglutaric acid in cells expressing mIDH1 (EC50 = 2.4 μM). Does not display cytotoxicity towards non-cancerous human cells. Phenotypically lethal.

Related Products: LM 10 1-Methyl-D-tryptophan 680C91
Potent cdk1/2 inhibitor
5654 | BMS 265246

IC50 values are 6, 9 and 230 nM for cdk1, cdk2 and cdk4, respectively. Inhibits proliferation of HCT-116 colon cancer cells in vitro.

Related Products: Ro 3306 Senexin A CGP 60474
Potent and selective inhibitor of integrins αvβ3 and αvβ5
5870 | Cilengitide

IC50 values are 4.1 and 70 nM for αvβ3 and αvβ5, respectively. Exhibits ~10-fold selectivity over gpIIb/IIIa. Increases endothelial monolayer permeability. Also exhibits antiangiogenic activity.

Related Products: BIO 1211 TC-I 15 BIO 5192
ADAM 17 (TACE) and MMP inhibitor; orally bioavailable
5960 | TMI 1

IC50 values are 3, 4.7, 6.6, 8.4, 12, 26 and 26 nM for MMP-13, MMP-2, MMP-1, ADAM 17, MMP-9, MMP-7 and MMP-14, respectively. Suppresses TNF-α production in an acute LPS-mouse model. Reduces severity score in an in vivo model of rheumatoid arthritis. Displays selective cytotoxicity towards tumor cells and cancer stem cells in vitro. Induces tumor apoptosis in a breast cancer in vivo model. Orally bioavailable.

Related Products: WAY 170523 GM 6001 GI 254023X

August 2016

Potent inhibitor of EGFR, ErbB2 and Abl receptor tyrosine kinases
4397 | AV 412

IC50 values are 0.5-2, 19 and 41 nM, respectively. Also weak inhibitor of FLT1 and Src. Inhibits EGFR and ErbB2 autophosphorylation in vitro in NSCLC and T-47D breast cancer cell lines, respectively. Inhibits tumor growth of EGFR-overexpressing A431 and ErbB2 overexpressing BT-474 tumor xenografts in mice.

Related Products: AG 1478 Iressa Bosutinib
Potent P2Y12 antagonist; cell permeable
5650 | SAR 216471

IC50 = 17 nM. Displays antiplatelet and antithrombotic activity in vivo. Orally available.

Related Products: (+)-Clopidogrel hydrogen sulfate AR-C 66096 PSB 0739
Potent and selective type I PRMT inhibitor
5713 | MS 023

IC50 values are 8, 8, 30, 83 and 119 nM for PRMT6, PRMT8, PRMT1, PRMT4 and PRMT3, respectively. Exhibits no significant activity against type II and III PRMTs, PKMTs, DNMTs, KDMs and reader proteins. Reduces global arginine asymmetric dimethylation levels in vitro.

Related Products: 3-Deazaneplanocin A Furamidine SGC 707
Selective tryptophan 2,3-dioxygenase (TDO) inhibitor
5794 | LM 10

IC50 values are 0.62 and 2 μM for human and mouse TDO, respectively. Exhibits selectivity for TDO over IDO, MAO-A, MAO-B, and a panel of receptors and transporters. Reduces growth of TDO-expressing P815 mastocytoma tumors in mice. Orally bioavailable.

Related Products: 680C91 DMXAA 1-Methyl-D-tryptophan
Potent microsomal prostaglandin E synthase 1 (mPGES-1) inhibitor
5917 | PF 9184

PIC50 values are 16.5 and 1080 nM for human and rat mPGES-1, respectively. Exhibits >6500-fold selectivity for mPGES-1 over COX-1 and COX-2. Inhibits IL-1β-induced PGE2 synthesis in vitro.

Related Products: Alprostadil HQL 79 TFC 007

July 2016

Potent and selective BRD9 and BRD7 inhibitor; orally active
5590 | BI 9564

Kd values are 14 and 239 nM, respectively. Exhibits selectivity for BRD9/7 over 48 other bromodomains, 324 kinases and 55 GPCRs. Inhibits proliferation of AML cell lines in vitro and reduces AML tumor xenograft growth in vivo. Cell permeable and orally active.

Related Products: (+)-JQ1 I-BET 151 PFI 4
Nrf2 activator; inhibits Nrf2/Keap1 interaction
5707 | RA 839

Kd = 6 μM. Suppresses LPS-induced iNOS and nitric oxide expression in macrophages. Anti-inflammatory.

Related Products: Curcumin CDDO Im Oltipraz
Potent and selective S1P5 agonist
5766 | A 971432

EC50 values are 4.1 and 5.7 nM in cAMP and GTPγS assays, respectively. Exhibits 60-fold selectivity over S1P1, and >1,600-fold selectivity over S1P2-4 and a panel of 129 kinases and 79 receptors. Improves blood-brain barrier integrity in vitro and reverses age-related cognitive decline in vivo. Orally available.

Related Products: Sphingosine-1-phosphate JTE 013 TY 52156
Potent TNKS1/2 inhibitor
5775 | AZ 6102

IC50 values are 1 and 3 nM, respectively. Exhibits >100-fold selectivity for TNKS1/2 over PARP-1, PARP-2 and PARP-6. Inhibits Wnt signaling in DLD-1 cells (IC50 = 5 nM). Exhibits moderate oral bioavailability.

Related Products: JW 55 XAV 939 IWP 4
Selective ASIC1a inhibitor; analgesic
5938 | Mambalgin 1

IC50 values are 192 and 72 nM for human ASIC1a and ASIC1a/1b dimer, respectively. Binds to closed/inactive channel. Selective for ASIC1a over ASIC2a, ASIC3, TRPV1, P2X2, 5-HT3, Nav1.8, Cav3.2 and Kv1.2 channels. Increases latency of tail and paw withdrawal in mouse tail-flick and paw-flick tests. Analgesic.

Related Products: Amiloride APETx2 Psalmotoxin 1

June 2016

High affinity and selective EP4 antagonist
5327 | BGC 20-1531

Ki = 3 nM. Exhibits >2500-fold selectivity for EP4 over EP2 and EP3. Also selective over a range of other prostanoid receptors, ion channels, transporters and enzymes. Inhibits PGE2-induced vasodilation of middle cerebral and meningeal arteries in vitro, and carotid blood flow in vivo. Orally bioavailable.

Related Products: L-161,982 ONO AE3 208 TCS 2510
High affinity and selective HNE1 inhibitor
5651 | ONO 6818

Ki =12 nM. Exhibits >100-fold less activity at other related proteases including trypsin, pancreatic elastase, collagenase and murine macrophage elastase. Inhibits NA-induced lung hemorrhaging and suppresses leukocyte levels in an in vivo model of COPD. Orally active.

Related Products: SSR 69071 Nafamostat Sivelestat sodium salt
Oct3/4 inducer
5664 | O4I2

Promotes Oct3/4 expression and stabilizes the Oct3/4 protein in HEK293 cells. Induces expression of the pluripotent-associated genes Lin28, Sox2 and Nanog, and suppresses Rex1. Induces a 15-fold increase in Oct3/4 expression in human primary fibroblasts.

Related Products: Thiazovivin 3-Deazaneplanocin A OAC-1
LSD1 inhibitor
5714 | S 2101

IC50 = 990 nM; Ki = 610 nM. Exhibits selectivity for LSD1 over MAO-B and MAO-A (Ki values are 17 and 110 μM, respectively).

Related Products: Tranylcypromine RN 1 GSK LSD 1
Potent and selective PI 3-kinase β inhibitor
5832 | TGX 221

IC50 values are 0.007, 0.1, 3.5 and 5 μM for β, δ, γ and α isoforms, respectively. Shows >1,000-fold selectively for PI 3-kinase β over a range of other kinases. Inhibits thrombus formation in animal models.

Related Products: LY 294002 Wortmannin 3-Methyladenine

May 2016

Potent TBK1 inhibitor
5067 | MRT 68601

IC50 = 6 nM. Inhibits the formation of autophagosomes in lung cancer cells.

Related Products: BX 795 Amlexanox MRT 67307
Potent and selective SMYD2 inhibitor
5365 | LLY 507

IC50 = 15 nM. Exhibits >100-fold selectivity for SMYD2 over 25 other methyltransferases including SMYD3, SUV420H1 and SUV420H2. Also exhibits selectivity over a panel of GPCRs, nuclear receptors and cytochrome P450 enzymes. Inhibits SMYD2-mediated p53 methylation in vitro. Also inhibits proliferation of a range of esophageal, liver and breast cancer cell lines.

Related Products: 3-Deazaneplanocin A A 366 (S)-PFI 2
Potent Nurr1 activator
5699 | IP7e

EC50 = 3.9 nM. Delays onset and reduces severity of symptoms in mice with experimental autoimmune encephalomyelitis (EAE). Also suppresses NF-κB signaling. Brain penetrant and orally bioavailable.

Related Products: Ro 106-9920 Withaferin A Bengamide B
High affinity and selective presynaptic CHT inhibitor
5725 | ML 352

Ki = 92 nM. Exhibits selectivity for CHT over dopamine, serotonin and noradrenaline transporters; acetylcholinesterase and cholineacetyltransferase; and a panel of 65 other GPCRs, ion channels and transporters.

Related Products: (±)-Vesamicol Indatraline Bupropion
CXCR4 allosteric agonist
5795 | ATI 2341

EC50 = 194 nM. Induces chemotaxis in CXCR4-expressing cells in vitro. Mobilizes polymorphonuclear neutrophils (PMNs) and hematopoietic stem and progenitor cells (HSPCs) from bone marrow niche in vivo. Exhibits biased signaling towards Gi proteins over G13 and β-arrestin.

Related Products: AMD 3100 octahydrochloride VUF 11207 CTCE 9908

April 2016

Potent Chk2 inhibitor
4968 | CCT 241533

IC50 = 3 nM. Shows >63-fold selectivity for Chk1 over Chk2 and a panel of 84 other kinases. Inhibits Chk2 activation in response to etoposide-induced DNA damage in HT29 cells. Blocks ionizing radiation-induced apoptosis of mouse thymocytes.

Related Products: SB 218078 TCS 2312 AZD 7762
High affinity and selective CB2 inverse agonist
5039 | SR 144528

Ki = 0.6 nM. Exhibits >700-fold selectivity for CB2 over CB1 receptors. Blocks the effects of CP 55,940 (Cat. No. 0949) on forskolin-sensitive adenylyl cyclase activity and MAPK in CHO cells expressing CB2 receptors. Also blocks CP 55,940-induced B-cell activation. Orally bioavailable.

Related Products: AM 630 JWH 133HU 308
Potent and selective CXCR2 antagonist
5660 | NVP CXCR2 20

IC50 = 40 nM. Exhibits selectivity for CXCR2 over a panel of 49 other GPCRs. Orally bioavailable.

Related Products: SB 225002 (±)-NBI 74330 CTCE 9908
Potent and selective GPR139 agonist
5666 | JNJ 63533054

EC50 = 16 nM. Selective for GPR139 over a panel of GPCRs, ion channels and transporters, including GPR142. Brain and cell penetrant. Orally bioavailable.

Related Products: TC-O 9311 TC-G 1008 Prosaptide TX14(A)
Selective CBP/p300 bromodomain inhibitor
5801 | PF CBP1

IC50 values are 125 and 363 nM for CBP and p300, respectively. Exhibits >100-fold selectivity for CBP over BRD4. Also exhibits selectivity over a panel of other bromodomains. Reduces LPS-induced IL-1β, IL-6 and IFN-β expression in macrophages in vitro. Also downregulates RGS4 expression in primary cortical neurons in vitro.

Related Products: I-BET 151 I-CBP 112 GSK 2801

March 2016

Potent and selective breast tumor kinase (Brk) inhibitor
5579 | Tilfrinib

IC50 = 3.15 nM. Exhibits >1000-fold selectivity for Brk over a panel of other kinases. Inhibits proliferation of breast cancer cells in vitro.

Related Products: A 419259 KB SRC 4 Temsirolimus
Potent and selective dual mTORC1 and 2 inhibitor
5615 | AZD 3147

IC50 = 1.5 nM. Exhibits >300-fold selectivity for mTOR over PI 3-kinase isoforms. Orally bioavailable.

Related Products: Rapamycin Torin 1 PP 242
Potent LXR antagonist
5694 | GSK 2033

pIC50 = 7.5. Enhances T-cell proliferation and blocks T 0901317-antiproliferative activity on T-cells. Cell permeable.

Related Products: GW 4064 GW 3965 DY 268
Potent γ-secretase inhibitor
5751 | PF 3084014

IC50 values are 1.2 and 6.2 nM in whole cell and cell-free assays, respectively. Reduces Aβ in brain, CSF and plasma in mice and guinea pigs.

Related Products: DAPT L-685,458 MRK 560
High affinity 15-PGDH inhibitor
5759 | SW 033291

Ki = 0.1 nM. Increases PGE2 levels in A549 cells in vitro, as well as in bone marrow, colon, lung and liver in mice. Promotes hematopoiesis, recovery from DSS-induced colitis, and hepatocyte proliferation after partial hepatectomy in mice.

Related Products: Alprostadil CH 223191 16,16-Dimethyl Prostaglandin E2

February 2016

Potent and selective GRK2/3 inhibitor
5642 | CMPD101

Potent and selective GRK2/3 inhibitor (IC50 values are 32 and 54 nM for GRK3 and GRK2, respectively). Exhibits selectivity for GRK2/3 over GRK1/5. Reduces DAMGO-induced desensitization and internalization of μ-opioid receptors.

Related Products: 8-Bromo-cGMP Gallein GRK2i
OX2 receptor antagonist; orally bioavailable
5645 | IPSU

OX2 receptor antagonist. Exhibits approximately six-fold selectivity for OX2 versus OX1 receptors. Decreases activity and increases sleep time in mice during the active phase, without affecting REM/NREM balance. Orally bioavailable. Brain penetrant.

Related Products: [Ala11,D-Leu15]-Orexin B TCS OX2 29 EMPA
Potent and selective HDAC2/3 inhibitor
5647 | MI 192

Potent and selective HDAC2/3 inhibitor (IC50 values are 16 and 30 nM, respectively). Exhibits >250-fold selectivity for HDAC2/3 over other HDAC isoforms. Promotes apoptosis of leukemia cell lines in vitro. Also attenuates IL-6 production in rheumatoid arthritis PBMCs in vitro.

Related Products: MC 1568 SAHA UF 010
Potent FXR antagonist
5656 | DY 268

Potent FXR antagonist (IC50 = 7.5 nM). Exhibits no detectable cytotoxicity in cell-based assays.

Related Products: GW 4064 GW 3965 Fexaramine
MAP4K4 (HGK) inhibitor
5752 | PF 06260933

MAP4K4 (HGK) inhibitor (IC50 = 140 nM). Also inhibits MINK and TNIK (IC50 values are 8 and 13 nM, respectively). Improves fasting hyperglycemia in mice. Orally active.

Related Products: AEG 3482 (5Z)-7-Oxozeaenol FR 180204

January 2016

Potent stearoyl-CoA desaturase 1 inhibitor
4845 | A 939572

IC50 = 0.4 nM. Selective for SCD1 over a range of kinases and hERG channels. Inhibits proliferation of squamous cell carcinoma FaDu cells in vitro. Also induces cell death of undifferentiated human embryonic stem cells (ESCs). Orally bioavailable.

Related Products: STF 31 PluriSln 1 Wnt-C59
Potent and selective NHE1 inhibitor
5512 | BIX NHE1 inhibitor

IC50 = 31 nM. Selective for NHE1 over NHE2 and NHE3. Prevents ischemic damage in an ischemia reperfusion injury isolated rat heart model ex vivo. Prevents phenylephrine-induced cardiomyocyte hypertrophy in vitro, and attenuates cardiac hypertrophy and left ventricular dysfunction postinfarction in rats. Orally bioavailable.

Related Products: KB-R7943 EIPA Cariporide
Potent and selective PERK inhibitor
5517 | AMG PERK 44

IC50 = 6 nM. Exhibits >160-fold selectivity for PERK over B-Raf and GCN2, as well as a panel of 387 other kinases. Orally bioavailable.

Related Products: GSK 2606414 trans-ISRIB Salubrinal
Selective BAZ2A and BAZ2B inhibitor
5635 | GSK 2801

IC50 values are 0.40 and 0.43 μM, respectively. Selective for BAZ2A/B over TAF1L and BRD9. Cell permeable and orally available.

Related Products: (+)-JQ1 I-CBP 112 PFI 4
Potent LRRK2 inhibitor; neuroprotective
5716 | PF 06447475

IC50 = 3 nM. Attenuates α-synuclein-induced dopaminergic neurodegeneration and neuroinflammation in G2019S-LRRK2 expressing rats. Also neuroprotective in wild type rats. Brain penetrant.

Related Products: LRRK2-IN-1 NQDI 1 GSK2578215A

Quick Order

Find multiple products by catalog number

divider line

Sign up to our E-Alerts

Win an iPad Air 2 or Mini 4

e-alerts

To receive the latest product news relevant to your interests, sign up to our e-alerts or update your details, and you will automatically be entered into the draw to win an iPad Air 2 or Mini 4 of your choice.

divider line

Bio-Techne Events

Neuroscience 2016

Neuroscience 2016

November 12 - 16, 2016

San Diego, CA, USA

Booth: 3217